Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Loa Loa (eye worm) | nuclear factor I | 0.0005 | 0.0075 | 0.0075 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0008 | 0.0389 | 0.1391 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0008 | 0.0389 | 0.1391 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0008 | 0.0389 | 0.0816 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0008 | 0.0389 | 0.1391 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0053 | 0.4222 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.2794 | 0.5 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0389 | 0.0389 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.2794 | 0.5 |
Echinococcus multilocularis | smad | 0.0008 | 0.0389 | 0.1391 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0007 | 0.0281 | 0.1005 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0006 | 0.0228 | 0.5 |
Brugia malayi | MH1 domain containing protein | 0.0005 | 0.0075 | 0.0075 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0228 | 0.5 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0389 | 0.0816 |
Echinococcus granulosus | Smad4 | 0.0008 | 0.0389 | 0.1391 |
Brugia malayi | CXXC zinc finger family protein | 0.0028 | 0.208 | 0.208 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0389 | 0.0389 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0281 | 0.0589 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0389 | 0.0816 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.012 | 1 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0028 | 0.208 | 0.4366 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0006 | 0.0228 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0389 | 0.0816 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0427 | 0.1527 |
Loa Loa (eye worm) | histone methyltransferase | 0.0009 | 0.0427 | 0.0427 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.2794 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0004 | 0.0029 | 0.0062 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0028 | 0.208 | 0.208 |
Brugia malayi | hypothetical protein | 0.0036 | 0.2794 | 0.2794 |
Loa Loa (eye worm) | Smad1 | 0.0008 | 0.0389 | 0.0389 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.012 | 1 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0228 | 0.5 |
Echinococcus multilocularis | cpg binding protein | 0.0029 | 0.2217 | 0.7934 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.2794 | 0.5864 |
Brugia malayi | MH1 domain containing protein | 0.0005 | 0.0075 | 0.0075 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0007 | 0.0281 | 0.1005 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0228 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0007 | 0.0281 | 0.1005 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0228 | 0.5 |
Schistosoma mansoni | Smad4 | 0.0008 | 0.0389 | 0.0816 |
Schistosoma mansoni | cpg binding protein | 0.0029 | 0.2217 | 0.4653 |
Schistosoma mansoni | cpg binding protein | 0.0029 | 0.2217 | 0.4653 |
Echinococcus multilocularis | Smad4 | 0.0008 | 0.0389 | 0.1391 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.2794 | 1 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0008 | 0.0389 | 0.0389 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0389 | 0.0389 |
Onchocerca volvulus | 0.0028 | 0.208 | 1 | |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0389 | 0.0389 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.2794 | 0.5864 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0008 | 0.0389 | 0.0389 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0427 | 0.1527 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0007 | 0.0281 | 0.1005 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Echinococcus granulosus | smad | 0.0008 | 0.0389 | 0.1391 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0008 | 0.0389 | 0.1391 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0009 | 0.0417 | 0.0417 |
Schistosoma mansoni | smad | 0.0008 | 0.0389 | 0.0816 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.2794 | 0.5 |
Echinococcus granulosus | cpg binding protein | 0.0029 | 0.2217 | 0.7934 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Brugia malayi | Smad1 | 0.0008 | 0.0389 | 0.0389 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0228 | 0.5 |
Trichomonas vaginalis | helicase, putative | 0.0006 | 0.0228 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0228 | 0.5 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0059 | 0.4765 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.2794 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0228 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0.0075 | 0.0075 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.